Market Closed -
Nasdaq
01:30:00 29/06/2024 am IST
|
5-day change
|
1st Jan Change
|
0.6932
USD
|
+3.77%
|
|
+4.40%
|
-4.12%
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
58.73
|
132.3
|
110.8
|
36.41
|
25.39
|
24.44
|
-
|
-
|
Enterprise Value (EV)
1 |
58.73
|
132.3
|
110.8
|
36.41
|
25.39
|
24.44
|
24.44
|
24.44
|
P/E ratio
|
-2.3
x
|
-3.66
x
|
-2.77
x
|
-0.57
x
|
-1.9
x
|
-6.93
x
|
-1.38
x
|
-
|
Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
-
|
-
|
-
|
2.31
x
|
0.7
x
|
0.58
x
|
0.95
x
|
-
|
EV / Revenue
|
-
|
-
|
-
|
2.31
x
|
0.7
x
|
0.58
x
|
0.95
x
|
-
|
EV / EBITDA
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
EV / FCF
|
-2.55
x
|
-5.33
x
|
-3.45
x
|
-4.04
x
|
-
|
-1.39
x
|
-0.94
x
|
-0.76
x
|
FCF Yield
|
-39.2%
|
-18.8%
|
-29%
|
-24.7%
|
-
|
-72%
|
-106%
|
-132%
|
Price to Book
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Nbr of stocks (in thousands)
|
17,376
|
24,728
|
29,391
|
34,352
|
35,119
|
35,255
|
-
|
-
|
Reference price
2 |
3.380
|
5.350
|
3.770
|
1.060
|
0.7230
|
0.6932
|
0.6932
|
0.6932
|
Announcement Date
|
26/03/20
|
24/03/21
|
23/03/22
|
23/03/23
|
25/03/24
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
-
|
-
|
-
|
15.76
|
36.08
|
41.99
|
25.75
|
-
|
EBITDA
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
EBIT
1 |
-26.73
|
-29.55
|
-37.79
|
-62.08
|
-14.52
|
-4.364
|
-27.67
|
-
|
Operating Margin
|
-
|
-
|
-
|
-393.91%
|
-40.24%
|
-10.39%
|
-107.44%
|
-
|
Earnings before Tax (EBT)
1 |
-25.6
|
-29.81
|
-39.05
|
-62.43
|
-12.76
|
-3.845
|
-26.37
|
-
|
Net income
1 |
-25.6
|
-29.81
|
-39.05
|
-62.43
|
-13.34
|
-3.374
|
-19.05
|
-36.3
|
Net margin
|
-
|
-
|
-
|
-396.14%
|
-36.96%
|
-8.03%
|
-73.99%
|
-
|
EPS
2 |
-1.470
|
-1.460
|
-1.360
|
-1.850
|
-0.3800
|
-0.1000
|
-0.5025
|
-
|
Free Cash Flow
1 |
-23.02
|
-24.83
|
-32.14
|
-9.012
|
-
|
-17.6
|
-26
|
-32.3
|
FCF margin
|
-
|
-
|
-
|
-57.19%
|
-
|
-41.91%
|
-100.97%
|
-
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
26/03/20
|
24/03/21
|
23/03/22
|
23/03/23
|
25/03/24
|
-
|
-
|
-
|
Fiscal Period: December |
2021 Q4
|
2022 Q1
|
2022 Q2
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
2025 Q1
|
2025 Q2
|
---|
Net sales
1 |
-
|
-
|
-
|
-
|
15.76
|
8.879
|
9.124
|
8.87
|
9.211
|
10.69
|
6.325
|
24.92
|
0.55
|
-
|
-
|
EBITDA
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
EBIT
1 |
-10.39
|
-37.33
|
-13.55
|
-13.24
|
2.042
|
-4.108
|
-3.591
|
-3.623
|
-3.2
|
-2.791
|
-5.167
|
12.13
|
-8.067
|
-
|
-
|
Operating Margin
|
-
|
-
|
-
|
-
|
12.96%
|
-46.27%
|
-39.36%
|
-40.85%
|
-34.74%
|
-26.11%
|
-81.69%
|
48.68%
|
-1,466.67%
|
-
|
-
|
Earnings before Tax (EBT)
1 |
-10.62
|
-37.42
|
-14.13
|
-13.66
|
2.773
|
-3.88
|
-3.335
|
-3.214
|
-2.326
|
-2.734
|
-5.283
|
12.45
|
-7.767
|
-
|
-
|
Net income
1 |
-10.62
|
-37.42
|
-14.13
|
-13.66
|
2.773
|
-3.94
|
-3.343
|
-3.71
|
-2.342
|
-2.734
|
-5.35
|
14.48
|
-9.358
|
-
|
-
|
Net margin
|
-
|
-
|
-
|
-
|
17.6%
|
-44.37%
|
-36.64%
|
-41.83%
|
-25.43%
|
-25.58%
|
-84.59%
|
58.08%
|
-1,701.55%
|
-
|
-
|
EPS
2 |
-0.3700
|
-1.170
|
-0.4100
|
-0.4000
|
0.0800
|
-0.1100
|
-0.1000
|
-0.1100
|
-0.0600
|
-0.0800
|
-0.1500
|
0.4050
|
-0.2650
|
-0.2000
|
-0.2000
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
23/03/22
|
12/05/22
|
15/08/22
|
14/11/22
|
23/03/23
|
11/05/23
|
09/08/23
|
08/11/23
|
25/03/24
|
09/05/24
|
-
|
-
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
-23
|
-24.8
|
-32.1
|
-9.01
|
-
|
-17.6
|
-26
|
-32.3
|
ROE (net income / shareholders' equity)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
ROA (Net income/ Total Assets)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Assets
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Book Value Per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Cash Flow per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Capex
1 |
0.07
|
0.2
|
0.06
|
0.28
|
-
|
-
|
-
|
-
|
Capex / Sales
|
-
|
-
|
-
|
1.77%
|
-
|
-
|
-
|
-
|
Announcement Date
|
26/03/20
|
24/03/21
|
23/03/22
|
23/03/23
|
25/03/24
|
-
|
-
|
-
|
Last Close Price
0.6932
USD Average target price
6.75
USD Spread / Average Target +873.74% Consensus |
1st Jan change
|
Capi.
|
---|
| -4.12% | 24.44M | | +55.32% | 815B | | +44.05% | 641B | | -6.75% | 352B | | +13.56% | 314B | | +10.68% | 303B | | +16.57% | 242B | | +2.04% | 224B | | +13.31% | 218B | | +8.48% | 168B |
Other Pharmaceuticals
|